Predictive and prognostic use of a mirna for high grade serous ovarian carcinoma therapeutic care
EP3781151A1
Bambuterol for the treatment of alzheimer's disease
EP3628315A1
Combination of acetylcholinesterase inhibitor and 5-ht4 receptor agonist as neuroprotective agent in the treatment of neurodegenerative diseases
EP3628660A1
Donecopride and flucopride as neuroprotective agents in the treatment of neurodegenerative diseases
EP3591075A1
Predictive and prognostic use of a mirna for high grade serous ovarian carcinoma therapeutic care
FR3083426A1
M-GAIACOL DERIVATIVES, THEIR PREPARATION AND THEIR USES
FR3006686A1
ACETYLCHOLINESTERASE INHIBITOR COMPOUNDS AND PROMOTING EFFECT OF 5HT4 SEROTONINERGIC RECEPTOR AGONISTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2682383A1
Derivatives of cyclopentane accole to a benzenic, thiophenic or furannic cycle, their preparation methods and their therapeutic application.
FR2673182A1
N,N'-Disubstituted piperazines, process for their preparation and their application in therapeutics
FR2665162A1
6H-Pyrido[3,2-b]carbazole derivatives, process for their preparation and their application in therapeutics
FR2580812A1
Method for attenuating or suppressing the electro-osmosis phenomenon in an electrophoresis cell and electrophoresis cell obtained thereby
